From the beginning, our members have been our focus. On their behalf, we’ve acted first to tackle the toughest challenges in health care, even when we acted alone. And we’re just getting started.
Express Scripts Flattens the Trajectory of the Diabetes Epidemic with SafeGuardRx Diabetes Care Value® Program
In its first year, the Express Scripts Diabetes Care Value program delivered nearly $43 million savings for plans; reduced heart attack risk in 15 percent of patients
Better health is only possible when medications are accessible and affordable. Our annual Express Scripts Drug Trend Report is the industry’s most comprehensive and influential examination of year-ove...
SafeGuardRx: Better Care at a Lower Cost for Patients and Payers
New data shows significantly improved clinical outcomes and lower drug spending for patients with complex, high-cost conditions enrolled in our SafeGuardRxSM programs.
SafeGuardRx: Delivering Better Health and Affordability
This first-to-market value-based program improves patient engagement and increases medication adherence while reducing costs for some of the costliest therapies.
Getting to the Rare Diagnosis: 7.6 Years and 7 Different Doctors
For patients with rare disease, getting to the right diagnosis is just the beginning of their journey. Our Rare Conditions Care Value Program® offers personalized support to help patients manage their...
A Call for A Consensus: Price Increases in Branded Drugs Are Unsustainable
Since 2008, brand medications have risen in price an average 232%. We need to work with pharma and the government for common-sense legislation and regulatory changes.
Our Federal Pharmacy Services team ensures that our nation's retirees, our active duty military personnel and their families receive the care they deserve.
Health Connect 360SM creates a holistic experience centered on a patient’s care, connecting all entities and supporting people through their engagement preferences to avoid gaps-in-care and...
Health care remains uncoordinated and costly. Consider diabetes, one of the most expensive conditions to manage. Prevalence continues to rise, despite advancements.
